BOSTON, July 10, 2014 /PRNewswire/ -- PAREXEL
International Corporation (NASDAQ: PRXL) will release financial
results for the Fourth Quarter and Fiscal Year 2014 on Wednesday, August 6th, 2014 after the
close of the stock market. The announcement will be available
on PAREXEL's website at www.PAREXEL.com and on the PR Newswire
website at www.prnewswire.com.
PAREXEL will host a conference call and live webcast at
10:00 a.m. EDT on Thursday, August 7th, 2014 to discuss
the results. To access the webcast, visit PAREXEL's website
at www.PAREXEL.com, and click on the Investors menu. This
webcast will continue to be accessible for one year following the
live broadcast. To participate via telephone, dial (408)
940-3886 and ask to join PAREXEL's Fourth Quarter and Fiscal Year
2014 conference call.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services organization, providing a broad range of
knowledge-based contract research, consulting, medical
communications, and technology solutions and services to the
worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, medical
education and reimbursement. PAREXEL Informatics provides advanced
technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 75
locations in 50 countries around the world, and has 15,335
employees. For more information about PAREXEL International
visit www.PAREXEL.com.
PAREXEL, PAREXEL Informatics, Perceptive, Perceptive MyTrials,
and "Your Journey. Our Mission." are trademarks or registered
trademarks of PAREXEL International Corporation or its
affiliates.
|
CONTACTS:
|
Jill Baker,
Corporate Vice President of Investor Relations
|
|
+1-781-434-4118
|
SOURCE PAREXEL International Corporation